Freely Filtered 031: Roxadustat

from Freely Filtered, a NephJC Podcast · host joel topf

Episode metadata supplied by the publisher feed · Published Mar 28, 2021

Embed this episode

Attribution link and audio player

What this episode covers

Roxadustat is the first HIF stabilizer up for FDA approval. There have been a number of roxa publications and today we took at the two most recent. One is a pooled analysis of incident dialysis patients: roxa versus epoetin alpha. And The second is a pre-dialysis CKD study of roxa versus placebo. Roxa represents well, but devils in the details. Join the filtrate as we go deep on roxa!

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Freely Filtered 031: Roxadustat

0:00 1:07:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Freely Filtered, a NephJC Podcast?

This episode is 1 hour and 7 minutes long.

When was this Freely Filtered, a NephJC Podcast episode published?

This episode was published on March 28, 2021.

Can I download this Freely Filtered, a NephJC Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!